Advertisement
U.S. markets closed
  • S&P Futures

    5,209.50
    -5.25 (-0.10%)
     
  • Dow Futures

    39,209.00
    -14.00 (-0.04%)
     
  • Nasdaq Futures

    18,192.75
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,048.40
    -1.40 (-0.07%)
     
  • Crude Oil

    82.61
    -0.11 (-0.13%)
     
  • Gold

    2,164.50
    +0.20 (+0.01%)
     
  • Silver

    25.34
    +0.08 (+0.30%)
     
  • EUR/USD

    1.0878
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    4.3400
    +0.0360 (+0.84%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2726
    -0.0002 (-0.02%)
     
  • USD/JPY

    149.2900
    +0.1920 (+0.13%)
     
  • Bitcoin USD

    65,622.76
    -2,292.95 (-3.38%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,596.29
    -144.15 (-0.36%)
     

Top Ranked Momentum Stocks to Buy for March 30th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:

Imprimis Pharmaceuticals, Inc. (IMMY): This pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessedthe Zacks Consensus Estimate for its current year earnings rising 10.7% over the last 60 days.

Imprimis Pharmaceuticals, Inc. Price and Consensus

Imprimis Pharmaceuticals, Inc. Price and Consensus | Imprimis Pharmaceuticals, Inc. Quote

Imprimis Pharmaceuticals’ shares gained 62.2% over the last three months higher than S&P 500’s gains of 5%. The company possesses a Momentum Score of A.

Imprimis Pharmaceuticals, Inc. Price

Imprimis Pharmaceuticals, Inc. Price | Imprimis Pharmaceuticals, Inc. Quote

Parker-Hannifin Corporation (PH): This manufacturer of motion control products has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.

Parker-Hannifin Corporation Price and Consensus

Parker-Hannifin Corporation Price and Consensus | Parker-Hannifin Corporation Quote

Parker-Hannifin’s shares gained 13.7% over the last three months. The company possesses a Momentum Score of A.

Parker-Hannifin Corporation Price

Parker-Hannifin Corporation Price | Parker-Hannifin Corporation Quote

DST Systems, Inc. (DST): This technology-based information processing solutions provider has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.

DST Systems, Inc. Price and Consensus

DST Systems, Inc. Price and Consensus | DST Systems, Inc. Quote

DST Systems’ shares gained 12.7% over the last three months. The company possesses a Momentum Score of A.

DST Systems, Inc. Price

DST Systems, Inc. Price | DST Systems, Inc. Quote

Merit Medical Systems, Inc. (MMSI): This medical products manufacturer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.

Merit Medical Systems, Inc. Price and Consensus

Merit Medical Systems, Inc. Price and Consensus | Merit Medical Systems, Inc. Quote

Merit Medical Systems’ shares gained 8.5% over the last three months. The company possesses a Momentum Score of A.

Merit Medical Systems, Inc. Price

Merit Medical Systems, Inc. Price | Merit Medical Systems, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here

Want to see all of today's Zacks Strong Buys?

Today's 5 additions are just the appetizer. You are welcome to download the full, up-to-the-minute list of 220 Zacks Rank #1 stocks free of charge. There is no better place to start your own stock search. Plus you can also access the full list of must-avoid Zacks Strong Sells and other private research.See the stocks free >>.      


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Parker-Hannifin Corporation (PH): Free Stock Analysis Report
 
Merit Medical Systems, Inc. (MMSI): Free Stock Analysis Report
 
Imprimis Pharmaceuticals, Inc. (IMMY): Free Stock Analysis Report
 
DST Systems, Inc. (DST): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement